This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chihao Zhao: Innovator in T Cell Receptor Technology
Introduction
Chihao Zhao is a prominent inventor based in Bethesda, MD (US). He has made significant contributions to the field of immunology, particularly in the development of T cell receptors that recognize mutated epidermal growth factor receptor (EGFR). His work is crucial for advancing cancer therapies and improving patient outcomes.
Latest Patents
Chihao Zhao holds a patent for "T Cell Receptors Which Recognize Mutated EGFR." This innovative patent highlights his expertise in creating targeted therapies that can enhance the immune system's ability to fight cancer.
Career Highlights
Zhao is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization underscores his commitment to public health and the advancement of medical research.
Collaborations
Chihao Zhao has collaborated with notable colleagues, including James C. Yang and Kenichi Hanada. These partnerships reflect a strong network of professionals dedicated to pushing the boundaries of scientific research.
Conclusion
Chihao Zhao's contributions to the field of immunology through his innovative patents and collaborations position him as a key figure in the ongoing fight against cancer. His work continues to inspire advancements in targeted therapies and improve the lives of many patients.